Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN5A | Q14524 | 6/20 | 0.50 |
| ▸ | SCN2A | Q99250 | 6/20 | 0.50 |
| ▸ | LMNA | P02545 | 4/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.40 |
| ▸ | HTT | P42858 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | HRH2 | P25021 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9866000 | 1.00 | SCN5A (0.50) | SCN5ASCN2ALMNAALDH1A1SMN1; SMN2 | |
| SCHEMBL9867640 | 0.94 | SCN5A (0.45) | SCN5ASCN2ALMNAALDH1A1SMN1; SMN2 | |
| SCHEMBL9867644 | 0.94 | SCN5A (0.45) | SCN5ASCN2ALMNAALDH1A1SMN1; SMN2 | |
| SCHEMBL9866012 | 0.93 | LMNA (0.53) | SCN5ASCN2ALMNAALDH1A1SMN1; SMN2 | |
| SCHEMBL9866309 | 0.92 | ALDH1A1 (0.42) | SCN5ASCN2ALMNAALDH1A1SMN1; SMN2 | |
| SCHEMBL9866315 | 0.92 | ALDH1A1 (0.42) | SCN5ASCN2ALMNAALDH1A1SMN1; SMN2 | |
| SCHEMBL9865901 | 0.92 | HPGD (0.40) | SCN5ASCN2ALMNAALDH1A1SMN1; SMN2 | |
| SCHEMBL9865896 | 0.92 | HPGD (0.40) | SCN5ASCN2ALMNAALDH1A1SMN1; SMN2 | |
| SCHEMBL9867007 | 0.91 | SCN5A (0.40) | SCN5ASCN2ALMNAALDH1A1SMN1; SMN2 | |
| SCHEMBL9866134 | 0.89 | SCN5A (0.37) | SCN5ASCN2ALMNASMN1; SMN2HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5021431-A | H-1 antagonist, h-2 agonist for treating hypertension, cardiac disease or arterial occlusion | HEUMANN PHARMA GMBH & CO. (DE) | 1991-06-04 | — | — | US | disclosed |
| EP-0199845-B1 | IMIDAZOLYLALKYLGUANIDIN DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | HEUMANN PHARMA GMBH & CO (DE) | 1990-08-01 | — | — | EP | disclosed |
| EP-0199845-A1 | Imidazolylalkylguanidin derivatives, process for their preparation and pharmaceutical compositions containing them | HEUMANN PHARMA GMBH & CO (DE) | 1986-11-05 | — | — | EP | disclosed |